Is DXC a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Stabilizing bookings, with revenue (ttm) at ~$12.5 billion. The bear case rests on the core risk is that the revenue decline keeps compounding: organic revenue fell about 6.7% in the June 2026 quarter, worse than the full-year guidance midpoint, and a business that shrinks fast enough can see cash flow fall with it. Analysts covering it are spread from $9.00 to $14.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The core risk is that the revenue decline keeps compounding: organic revenue fell about 6.7% in the June 2026 quarter, worse than the full-year guidance midpoint, and a business that shrinks fast enough can see cash flow fall with it. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $9.00, -33.9% from the $13.62 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Stabilizing bookings. The single most watched number at DXC is book-to-bill, the ratio of new contracts signed to revenue recognized. The most optimistic analyst target on DXC is $14.00, +2.8% from the $13.62 price. That figure is only reachable if this thesis works close to its best case.

The core risk is that the revenue decline keeps compounding: organic revenue fell about 6.7% in the June 2026 quarter, worse than the full-year guidance midpoint, and a business that shrinks fast enough can see cash flow fall with it. Generative AI could deflate pricing across IT services, hitting the labor-based maintenance work that makes up much of DXC's base. The company has a history of guidance misses, leadership turnover and restructuring charges, and law firms announced investigations after the May 2026 miss, though no new class action had been reported as filed as of October 2026. DXC also carries several billion dollars of debt and lease obligations, so a deterioration in cash flow would narrow its room for buybacks. Currency is another swing factor, since a large share of revenue comes from Europe, Australia and other non-US markets, so a stronger dollar reduces reported results. Finally, outsourcing renewals tend to come in lumps, and a quarter with several large contracts up for renegotiation can show price cuts that persist for the life of the new deal. The most pessimistic published target is $9.00, -33.9% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

IT services company formed from CSC and HPE's enterprise services arm, running outsourced infrastructure, applications and consulting for large enterprises.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Stabilizing bookings) stalling in the reported numbers rather than in the narrative, the risk above (the core risk is that the revenue decline keeps compounding: organic revenue fell about 6.7% in the June 2026 quarter, worse than the full-year guidance midpoint, and a business that shrinks fast enough can see cash flow fall with it) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

DXC Technology is an IT services company that runs, secures and modernizes technology for large enterprises and public-sector clients. Its Global Infrastructure Services segment manages data centers, cloud environments, end-user workplaces and cybersecurity operations, while Consulting and Engineering Services builds and maintains applications, data and analytics systems and engineering software. It also has a sizable insurance software and business process business. Most revenue comes from multi-year outsourcing contracts on mission-critical systems, often systems DXC or its predecessors CSC and HPE built decades ago. That gives it deep client relationships but also ties it to legacy technology that customers are steadily moving away from. The company is headquartered in Ashburn, Virginia, and trades on the New York Stock Exchange under the ticker DXC.

DXC's revenue has declined in most years since its 2017 formation, from more than $24 billion at the start to about $12.6 billion in fiscal 2026, as clients cut legacy outsourcing spend, moved workloads to public cloud or switched to cheaper providers. The company has also divested businesses along the way. Investors have repeatedly been disappointed by guidance misses, most recently in May 2026, when DXC said it missed its organic revenue guidance by roughly $75 million and the stock dropped about 21% in one day to around $9.43. The share price has since recovered sharply, closing at about $13.79 on October 15, 2026, among the day's top gainers, but remains far below its 2018 highs above $100. Net income margin also compressed sharply in the first half of 2026, which weighed on the shares alongside the revenue miss.

On standard metrics, yes. At about $13.79 a share (the October 15, 2026 close), DXC trades around 4.8 to 5.7 times its fiscal 2027 non-GAAP EPS guidance of $2.40 to $2.90, and its roughly $700 million of annual free cash flow is roughly 30% of its approximately $2.3 billion market value. Those are some of the lowest multiples among large IT services firms. Whether that is a bargain or a value trap depends on how fast revenue keeps shrinking. If organic declines of 5% or more persist for years, earnings and cash flow will erode too, and a low multiple on falling numbers can stay low. Walnut describes these figures; it does not judge whether the price is right for any individual. Analyst price targets clustered around $11 in mid-2026, close to where the shares traded then, which signaled that professional coverage largely saw the low multiple as justified; the October rally has since carried the stock above those targets.